News
Just when Phoonk was all set to change the tide of his luck, Ram Gopal Varma is said to be in trouble again. Film financier Bharat Shah has filed a complaint with the Indian Motion Pictures ...
In this article, we are going to take a look at where Regencell Bioscience Holdings Limited (NASDAQ:RGC) stands against other stocks that posted double-, triple-digit gains last week. Micro- and ...
In this article, we are going to take a look at where Regencell Bioscience Holdings Ltd. (NASDAQ:RGC) stands against other micro-, small-cap firms that dominate Thursday’s gains. The stock ...
We first wrote on Regencell Bioscience (NASDAQ:RGC) and its preliminary trials for ASD/ADHD, in November 2021. At that time, the stock was trading around $20/share. It rose to $40 by mid-February ...
In this article, we are going to take a look at where Regencell Bioscience Holdings Limited (NASDAQ:RGC) stands against other healthcare stocks that are surging in 2025. After lagging behind the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results